Global Infectious Disease Testing Products Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 18.34 Billion |
 Market Size (Forecast Year) |
USD 28.73 Billion |
 CAGR |
% |
| Major Markets Players |
>全球传染病检测产品市场，按产品和服务（检测、试剂盒和试剂、仪器、服务和软件）、技术（免疫诊断、临床微生物学、聚合酶链反应、等温核酸扩增技术、DNA 测序和下一代测序、DNA 微阵列、其他技术）、疾病类型（肝炎、人类免疫缺陷病毒、沙眼衣原体生殖器感染和淋病、医院内获得性感染、人乳头瘤病毒、结核病、流感、其他）、最终用户（医院/临床实验室、参考实验室、医生办公室、学术/研究机构、其他最终用户）划分 - 行业趋势和预测到 2029 年。
传染病检测产品市场分析及规模
由细菌、病毒、真菌或寄生虫等生物引起的疾病被称为传染病。人体是各种微生物和细菌的家园。在大多数情况下，它们是有益的，甚至是安全的。但某些微生物在特定情况下有可能引起疾病。一些传染病可以从一个人传播到另一个人，并被认为具有传染性。空气、水、食物或土壤中的细菌可以传播其他传染病。它们也可以通过动物或叮咬昆虫等媒介传播。
Data Bridge Market Research 分析，传染病检测产品市场规模从 2021 年的 183.4 亿美元飙升至 2029 年的 287.3 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 5.77%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
传染病检测产品市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品和服务（检测、试剂盒、试剂、仪器、服务和软件）、技术（免疫诊断、临床微生物学、聚合酶链反应、等温核酸扩增技术、DNA 测序和下一代测序、DNA 微阵列、其他技术）、疾病类型（肝炎、人类免疫缺陷病毒、沙眼衣原体生殖器感染和淋病、医院内感染、人乳头瘤病毒、结核病、流感、其他）、最终用户（医院/临床实验室、参考实验室、医生办公室、学术/研究机构、其他最终用户） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Abbott (U.S.), BD (U.S.), bioMérieux (France), Bio-Rad Laboratories Inc. (U.S.), Danaher (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), Quidel Corporation (U.S.), Siemens (Germany), Thermo Fisher Scientific Inc. (U.S.), Johnson and Johnson Private Limited (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Cepheid (U.S.), Qiagen (Germany), OraSure Technologies, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
A chemluminescent immunoassay (ChLIA) is utilised for the qualitative detection of T. cruzi antibodies in human serum or plasma samples and is used to screen blood donors. An FDA-approved enzyme strip immunoassay (ESA) is utilised for confirmatory testing.
Infectious Disease Testing Products Market Dynamics
Drivers
- Increasing demand of personalised medicines
The development of genomics and proteomics is anticipated to boost market expansion. In the forecast period of 2022 to 2029, it is anticipated that additional factors such as rising government-funded programmes, rising shift from centralised laboratories to decentralised point-of-care testing, and rising demand for personalised medicines will boost the market for infectious disease testing products.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the market growth rate is the rising healthcare expenditure which helps improve its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like rising health-care spending, and the fast-growing diagnostic industry are driving the infectious disease testing products market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the infectious disease testing products market forward.
Opportunities
- Increase in the number of research and development activities
The increased prevalence of infectious diseases around the world is what is driving the global market for infectious disease testing. Furthermore, the expansion of the market during the projected period is anticipated to be fuelled by investments in healthcare infrastructure made by governments all over the world. Additionally, it is expected that an increase in research and development activities in the healthcare industry will support market growth over the next years.
Restraints/Challenges
On the other hand, the unfavourable reimbursement policies, high healthcare cost limiting the use of novel diagnostic techniques and poor distribution channel will obstruct the market's growth rate.
This infectious disease testing products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infectious disease testing products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Infectious Disease Testing Products Market
COVID-19 has led to the development of a number of novel, highly accurate, and cost-effective testing techniques. In order to assure the supply of testing kits in the healthcare industry, the Association of British HealthTech Industries (ABHI), BioIndustry Association (BIA), and the British In-Vitro Diagnostic Association (BIVDA) stated a global requirement for testing kit components on April 1, 2020. In order to determine who is affected by COVID-19, mass testing is carried out in South Korea. Additionally, lab tests are more accurate than testing kits. The producers are concentrating their efforts on creating sophisticated testing kits and using fresh approaches to save costs and win government approval.
Recent Development
- On March 18, 2020, The Food and Drug Administration (FDA) granted Abbott emergency use permission (EUA) for their molecular test to identify SARS-CoV-2, the virus that causes COVID-19. Approximately 150,000 laboratory tests will be conducted right away by the company.
- On March 31, 2020, Becton Dickinson and Company (BD) announced the release of a new Rapid Serology Test to identify COVID-19 exposure. The procedure is a new point-of-care test that can identify present or previous exposure to COVID-19 in less than 15 minutes by detecting antibodies in blood.
Global Infectious Disease Testing Products Market Scope
The infectious disease testing products market is segmented on the basis of product and services, technology, disease type, and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Assays
- Kits
- Reagents
- Instruments
- Services and Software
Technology
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- DNA Sequencing and Next-Generation Sequencing
- DNA Microarray
- Other Technologies
Disease Type
- Hepatitis
- Human Immunodeficiency Virus
- Chlamydia Trachomatis Genital Infection and Gonorrhea
- Hospital-Acquired Infections
- Human Papillomavirus
- Tuberculosis
- Influenza
- Others
End-User
- Hospitals/clinical laboratories
- Reference laboratories
- Physician offices
- Academic/research institutes
- Other end-users
Infectious Disease Testing Products Market Regional Analysis/Insights
The infectious disease testing products market is analysed and market size insights and trends are provided by country, product and services, technology, disease type, and end- users as referenced above.
The countries covered in the infectious disease testing products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infectious disease testing products market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Infectious Disease Testing Products Market Share Analysis
传染病检测产品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对传染病检测产品市场的关注有关。
传染病检测产品市场的一些主要参与者包括：
- 雅培（美国）
- BD（美国）
- 生物梅里埃（法国）
- Bio-Rad Laboratories Inc.（美国）
- 丹纳赫（美国）
- DiaSorin SpA（意大利）
- Meridian Bioscience Inc.（美国）
- Quidel Corporation（美国）
- 西门子（德国）
- 赛默飞世尔科技公司（美国）
- 强生私人有限公司（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- 造父变星（美国）
- Qiagen (德国)
- OraSure Technologies, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
